ARTICLE SUMMARY:
Pulse Biosciences, Kardium, and Field Medical are among the smaller companies planning to take on established strategics with novel pulsed field ablation technologies designed to make catheter treatment of arrythmias faster and safer.
Several smaller companies are joining the big cardiovascular medtech companies in advancing pulsed field ablation (PFA) technologies to take advantage of the technology’s inherent advantages in cardiac ablation.
